Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ahmed B Shamsulddin
Observed names:
Ahmed B. SHAMSULDDIN,
Ahmed B. Shamsulddin
ORCID:
0009-0006-0604-9202
Observed ORCID:
0009-0006-0604-9202
OpenAlex ID:
A5117444104
Regarding: Systolic blood pressure targets below 120 mm Hg are associated with reduced mortality: A meta‐analysis
2025
·
Ahmed B. Shamsulddin
·
Journal of Internal Medicine
·
3
Oral formulation and SGLT2i interaction: key nuances in semaglutide’s effect on atrial fibrillation
2025
·
Ahmed B Shamsulddin
·
European Journal of Preventive Cardiology
·
2
Beyond time alone: Reframing the definition of permanent atrial fibrillation with biomarkers
2025
·
Ahmed B. Shamsulddin
·
International Journal of Cardiology
·
1
Reframing the CHADS-P2A2RC score in chronic coronary syndrome: From ischemic risk stratification to a signal for caution
2025
·
Ahmed B. Shamsulddin
·
International Journal of Cardiology
·
1
Morbidity and mortality reduction in acute decompensated heart failure: a result of individualized monitoring or intervention principles?
2026
·
Ahmed B Shamsulddin
·
ESC Heart Failure
The ‘less side effect, more benefit’ hypothesis: explaining the colchicine paradox
2026
·
Ahmed B. Shamsulddin
·
Current Medical Research and Opinion
Hypertension management: is lower always better?
2026
·
Ahmed B. SHAMSULDDIN
·
Minerva Medica
Including Vonoprazan With PPIs Challenges the Drug-Interaction Hypothesis
2026
·
Ahmed B. Shamsulddin
·
JACC Asia
PDF
A novel hypothesis for stroke prediction, introducing CHA 2 DS 2 -VAScF
2026
·
Ahmed B. Shamsulddin
·
Current Medical Research and Opinion
Finerenone, New-Onset Atrial Fibrillation, and Prognosis in HFpEF/HFmrEF
2026
·
Ahmed B. Shamsulddin
·
JAMA Cardiology
Preventing stroke or myocardial infarction?: The new monotherapy crossroads in atrial fibrillation and coronary artery disease
2026
·
Ahmed B. Shamsulddin
·
The American Journal of Medicine
PDF
Methodological concerns in the OASIS-HF study: phenotypic misclassification and selection bias
2026
·
Ahmed B Shamsulddin
·
ESC Heart Failure
Equally Effective in CASTLE-HTx
2026
·
Ahmed B. Shamsulddin
·
JACC Heart Failure
Letter: Beta blocker withdrawal post-MI – the missed dimension of patient symptoms
2026
·
Ahmed B. Shamsulddin
·
EuroIntervention
Finerenone Withdrawal
2025
·
Ahmed B. Shamsulddin
·
Journal of the American College of Cardiology
High NT-proBNP in Heart Failure
2025
·
Ahmed B. Shamsulddin
·
JACC Heart Failure
The semaglutide paradox in non-overweight diabetes: a benefit without explanation
2025
·
Ahmed B Shamsulddin
·
European Heart Journal - Quality of Care and Clinical Outcomes
Beyond the biomarker war: is a hybrid, applicable strategy the answer?
2025
·
Ahmed B Shamsulddin
·
European Heart Journal Acute Cardiovascular Care
DOACs vs. VKAs for renal protection: An established superiority gives rise to a new clinical paradox
2025
·
Ahmed B. Shamsulddin
·
European Journal of Internal Medicine
Dissociation Between Mortality/Kidney Benefits and Neutral MACE Outcomes with ARNi in Heart Failure and Post-dialysis AKD Recovery
2025
·
Ahmed B. Shamsulddin
·
Cardiovascular Drugs and Therapy
Show more works
View as search
Works count:
20
Citation count:
7
H-index:
2
I10-index:
Year
Topic
Type
